North Cumbria Integrated Care Chooses Alcidion as Preferred EPR Supplier

Alcidion LtdThe trust, which provides hospital and community health care for approximately half a million people, has made a clinically-led decision to use Alcidion's Miya Precision platform. The modular EPR will enhance digital maturity and will support clinicians in the delivery of high quality, safe care for patients.

Intuitive design, ease of use, and interoperability with specialist systems that NCIC wishes to retain, were key benefits recognised by the trust's EPR evaluation team, which represented all services, at all levels, across the trust.

Dr Adrian Clements, executive medical director for NCIC, said: "We are pleased to have selected Alcidion as our preferred EPR provider on what is a significant advancement for North Cumbria in modernising our technological offering to provide a better service and experience for our patients, whilst also significantly increasing our digital maturity as a trust.

"Over the last few months, many of us have spent a great amount of time evaluating the various electronic patient record systems in order to reach the correct conclusion to help us implement the best possible dynamic EPR system. I feel assured and confident that selecting Alcidion will allow us to implement an EPR that enables high quality patient care, improves clinical safety and saves clinicians' valuable time."

NCIC, which already uses Alcidion's PCS patient administration system, provides services across two acute hospitals, eight community-based hospitals, eight integrated care communities, and a number of support staff locations over a large geographical footprint.

Miya Precision's full product suite will enable mobile working, streamline patient flow, support clinical decision-making processes, and will provide clinicians with real-time access to unified patient records.

Kate Quirke, Alcidion group managing director, said: "We are excited to build upon our existing relationship with NCIC as the trust's preferred EPR supplier. Having been the supplier of the trust’s patient administration system for more than eight years, we are now able to continue our relationship by bringing the full Miya Precision capabilities, alongside our partner applications, to deliver a comprehensive electronic patient record, accessible across NCIC.

"Alcidion's integrated, modular EPR solution allows NCIC to develop their existing digital footprint, protecting the trust’s existing investments and allowing healthcare professionals to realise the benefits of additional clinical capabilities, such as electronic noting and integrated observations, through integration with a number of existing systems. At a time when the health service is under enormous pressure, we see this increased speed to deliver value as a real opportunity for our customers."

NCIC is the second trust within the North East and North Cumbria Integrated Care System to choose Alcidion's Miya Precision as its EPR, with other trusts in the region also using technology provided by Alcidion.

Alcidion and NCIC will now finalise what is anticipated to be a 10-year contract, before commencing deployment of Miya Precision, which is targeted to begin in early 2025.

About North Cumbria Integrated Care NHS Foundation Trust

North Cumbria Integrated Care NHS Foundation Trust (NCIC) is part of the North East and North Cumbria Integrated Care System. It provides hospital and community health services to a population of around half a million people and is responsible for delivering over 70 services across 15 main locations; employing over 6,700 members of staff. NCIC was established on 1st October 2019, following the merger of Cumbria Partnership NHS Foundation Trust and North Cumbria University Hospitals NHS Trust. The estate consists of two acute care hospitals, eight community based hospitals, eight Integrated Care Communities (ICC) and a number of support staff locations over a large geographical footprint, working collaboratively with primary care networks, including 39 General Practices and an out of hours GP service.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 400 hospitals and 87 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...